This item is authorised by the following title:
For transitional provisions relating to the repeal of this instrument, see subsections 4(2) and (3) of the Therapeutic Goods (Poisons Standard—October 2025) Instrument 2025.
For transitional provisions relating to the repeal of this instrument, see subsections 4(2) and (3) of the Therapeutic Goods (Poisons Standard—October 2025) Instrument 2025.